CS
FURX

Credit Suisse’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Credit Suisse’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,858
Closed -$940K – 4883
2014
Q2 		$940K Sell
8,858
-7,026
-44% -$689K ﹤0.01% 3345
2014
Q1 		$1.38M Buy
15,884
+6,352
+67% +$490K ﹤0.01% 2827
2013
Q4 		$401K Buy
+9,532
New +$392K ﹤0.01% 3894
2013
Q3 		– Sell
-21,890
Closed -$746K – 4509
2013
Q2 		$746K Buy
+21,890
New +$768K ﹤0.01% 3022

Credit Suisse's FURX Position: Q3 2014 in Review

Credit Suisse sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 8,858 shares — an estimated $940K sold.

Credit Suisse first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $1.38M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Credit Suisse reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Credit Suisse sold 8,858 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $940K.
  • Credit Suisse first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Credit Suisse's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.38M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Credit Suisse's 13F filing for Q3 2014, filed 14 Nov 2014.